Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In June 2025, MBX Biosciences In announced it received preliminary feedback from the FDA on its planned Type B pre-IND meeting, supporting the advancement of its EL-22 program in combination with GLP-1 receptor agonists toward a Phase 2 clinical trial
A 1 mg/mL stock (approximately 220 M for cagrilintide) is a practical starting concentration that allows serial dilution to the nanomolar concentrations used in receptor binding and cell-based assays
GLP-1 medications like Mounjaro (tirzepatide) are transforming weight loss but are they safe for everyone
T.MobleyJ
Our BPC-157 research peptide is produced exclusively for laboratory and scientific research purposes
US$ 20.01
US$ 26.65
US$ 29.88
